Search for: "Bio-Reference Laboratories, Inc."
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
28 Feb 2010, 9:47 pm
Bio-Reference Laboratories, Inc. v. [read post]
14 May 2015, 6:30 am
Champion Laboratories, Inc. v. [read post]
14 Apr 2008, 9:22 am
Bio-Rad Laboratories, Inc. [read post]
25 Aug 2020, 2:06 am
The Federal Circuit decision in Bio-Rad Laboratories, Inc. v. 10X Genomics Inc., addresses several interesting issues. [read post]
15 Dec 2011, 7:56 am
The former Apple Inc. [read post]
2 May 2011, 3:14 pm
Owner Billups-Rothenberg sued Associated Regional and University Pathologists (ARUP) and Bio-Rad Laboratories for infringement. [read post]
18 Nov 2009, 4:57 am
Alcon Laboratories, Inc. et al. [read post]
18 Nov 2009, 4:57 am
Alcon Laboratories, Inc. et al. [read post]
18 Nov 2009, 4:57 am
Alcon Laboratories, Inc. et al. [read post]
29 Dec 2010, 2:57 am
(Kluwer Patent Blog) US: BIO sends letter to DOJ on ‘clear and convincing evidence’ question raised in Microsoft v. i4i (Patent Docs) US: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
19 Jul 2022, 6:33 am
Bio-Rad Laboratories, Inc. in which it stated that “Congress uses the phrase 'any rule or regulation of the [SEC]' in the same list in which it uses 'any provision of Federal law relating to fraud against shareholders,' which strongly suggests that there is a difference between the meaning of 'rule or regulation' and 'law.'” The First Circuit added that Baker’s interpretation of the phrase “rule or… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
1 Nov 2006, 5:09 pm
" disclaimed) for certain bio-chemical signaling pathway modulators and for related laboratory research and development services. [read post]
27 Aug 2011, 7:55 pm
Unigene Laboratories v. [read post]
6 Jan 2012, 1:08 am
” Among other cases the report cites is the FCPA-related derivative lawsuit involving Avon Products (refer here, footnote 5 to the financial statements), and the FCPA-related derivative lawsuits involving Bio-Rad Laboratories (refer here) and Tidewater, Inc. [read post]
25 Mar 2011, 8:29 pm
Bio-Engineered Supplements & Nutrition, Inc., 586 F.3d 1376, 1380 (Fed. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
